Expression microdissection adapted to commercial laser dissection instruments

Nature Protocols

Volumn 6, Issue 4, 2011, Pages 457-467

  Hanson, Jeffrey C ^a   Tangrea, Michael A ^a   Kim, Skye ^a   Armani, Michael D ^a   Pohida, Thomas J ^b   Bonner, Robert F ^c   Rodriguez Canales, Jaime ^a   Emmert Buck, Michael R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE VINYL ACETATE COPOLYMER;

ACCURACY; ARTICLE; CELL COUNT; CELL ISOLATION; CELL SELECTION; CLINICAL PROTOCOL; DEVICE SAFETY; EQUIPMENT DESIGN; EXPERIMENTAL DESIGN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LASER CAPTURE MICRODISSECTION; LASER MICRODISSECTION; PRIORITY JOURNAL; TARGET CELL; TISSUE PREPARATION;

CELL SEPARATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; LASERS; MICRODISSECTION; POLYVINYLS;

ANIMALIA;

EID: 79952777929     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2010.202     Document Type: Article

References (27)

1. Emmert-Buck, M.R. et al. Laser capture microdissection. Science 274, 998-1001 (1996). (Pubitemid 26398425)
2. Bonner, R.F. et al. Laser capture microdissection: molecular analysis of tissue. Science 278, 1481-1483 (1997).
3. Hunt, J.L. & Finkelstein, S.D. Microdissection techniques for molecular testing in surgical pathology. Arch. Pathol. Lab. Med. 128, 1372-1378 (2004). (Pubitemid 39627474)
4. Espina, V. et al. Laser-capture microdissection. Nat. Protoc. 1, 586-603 (2006).
5. Dupont Jensen, J. et al. PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer. Clin. Cancer Res. published online, doi:10.1158/1078-0432.CCR-10-1133 (12 October 2010).
6. Pinós, T. et al. A novel mutation in the mitochondrial tRNA(Ala) gene (m.5636T > C) in a patient with progressive external ophthalmoplegia. Mitochondrion 11, 228-233 (2011).
7. Yang, X. et al. Stromal microenvironment processes unveiled by biological component analysis of gene expression in xenograft tumor models. BMC Bioinformatics 11 (Suppl 9), S11 (2010).
8. Erickson, H.S. et al. Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples. Nat. Protoc. 4, 902-922 (2009).
9. Johann, D.J. et al. Approaching solid tumor heterogeneity on a cellular basis by tissue proteomics using laser capture microdissection and biological mass spectrometry. J. Proteome. Res. 8, 2310-2318 (2009).
10. Klein, C.J. et al. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch. Neurol. published online, doi:10.1001/archneurol.2010.261 (11 October 2010).
11. Tangrea, M.A. et al. Expression microdissection: operator-independent retrieval of cells for molecular profling. Diagn. Mol. Pathol. 13, 207-212 (2004). (Pubitemid 39552241)
12. Hanson, J.A. et al. Gene promoter methylation in prostate tumor-associated stromal cells. J. Natl. Cancer Inst. 98, 255-261 (2006). (Pubitemid 43264709)
13. Grover, A.C. et al. Tumor-associated endothelial cells display GSTP1 and RARbeta2 promoter methylation in human prostate cancer. J. Transl. Med. 4, 13 (2006).
14. Goldstein, S.R., McQueen, P.G. & Bonner, R.F. Thermal modeling of laser capture microdissection. Appl. Opt. 37, 7378-7391 (1998). (Pubitemid 128659484)
15. Perlmutter, M.A. et al. Comparison of snap freezing versus ethanol fxation for gene expression profling of tissue specimens. J. Mol. Diagn. 6, 371-377 (2004). (Pubitemid 39517406)
16. Leiva, I.M., Emmert-Buck, M.R. & Gillespie, J.W. Handling of clinical tissue specimens for molecular profling studies. Curr. Issues Mol. Biol. 5, 27-35 (2003). (Pubitemid 36675581)
17. Fend, F. et al. Immuno-LCM: laser capture microdissection of immunostained frozen sections for mRNA analysis. Am. J. Pathol. 154, 61-66 (1999). (Pubitemid 29031612)
18. Rodriguez-Canales, J. et al. Identifcation of a unique epigenetic sub-microenvironment in prostate cancer. J. Pathol. 211, 410-419 (2007). (Pubitemid 46332552)
19. Macdonald, J.A., Murugesan, N. & Pachter, J.S. Validation of immuno-laser capture microdissection coupled with quantitative RT-PCR to probe blood-brain barrier gene expression in situ. J. Neurosci. Methods 174, 219-226 (2008).
20. Liu, Y. et al. Immuno-laser capture microdissection of frozen prolactioma sections to prepare proteomic samples. Colloids Surf. B Biointerfaces 71, 187-193 (2009).
21. Fend, F., Kremer, M. & Quintanilla-Martinez, L. Laser capture microdissection: methodical aspects and applications with emphasis on immuno-laser capture microdissection. Pathobiology 68, 209-214 (2000). (Pubitemid 32247257)
22. Eberle, F.C. et al. Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens. J. Mol. Diagn. 12, 394-401 (2010).
23. Buckanovich, R.J. et al. Use of immuno-LCM to identify the in situ expression profle of cellular constituents of the tumor microenvironment. Cancer Biol. Ther. 5, 635-642 (2006). (Pubitemid 44024718)
24. von Smolinski, D., Blessenohl, M., Neubauer, C., Kalies, K. & Gebert, A. Validation of a novel ultra-short immunolabeling method for high-quality mRNA preservation in laser microdissection and real-time reverse transcriptase-polymerase chain reaction. J. Mol. Diagn. 8, 246-253 (2006). (Pubitemid 43811249)
25. Brown, A.L. & Smith, D.W. Improved RNA preservation for immunolabeling and laser microdissection. RNA 15, 2364-2374 (2009).
26. Cha, S. et al. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology. Mol. Cell. Proteomics 9, 2529-2544 (2010).
27. Nonn, L., Vaishnav, A., Gallagher, L. & Gann, P.H. mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. Exp. Mol. Pathol. 88, 45-51 (2010).